# ADMA Biologics (ADMA) — Analyst Forecast

ADMA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/adma/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | $17.00 |
| May 7, 2026 | Mizuho | Maintained | Outperform | $20.00 |
| May 7, 2026 | Canaccord Genuity | Maintained | Buy | $18.00 |
| Apr 21, 2026 | Canaccord Genuity | Initiated Coverage | Buy | $21.00 |
| Apr 13, 2026 | Mizuho | Maintained | Outperform | $24.00 |
| Mar 26, 2026 | Cantor Fitzgerald | Downgraded | Overweight → Neutral | — |
| May 8, 2025 | Raymond James | Maintained | Strong Buy | $32.00 |
| Mar 4, 2025 | Cantor Fitzgerald | Maintained | Overweight | $25.00 |
| Nov 8, 2024 | Raymond James | Maintained | Strong Buy | $25.00 |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | $26.00 |
| Oct 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $18.00 |
| Sep 20, 2024 | Cantor Fitzgerald | Maintained | Overweight | $20.00 |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | $18.00 |
| Aug 9, 2024 | Cantor Fitzgerald | Maintained | Overweight | $20.00 |
| Jul 9, 2024 | Cantor Fitzgerald | Maintained | Overweight | $15.00 |
| Jun 20, 2024 | Mizuho | Maintained | Buy | $14.00 |
| May 10, 2024 | Mizuho | Maintained | Buy | $12.00 |
| May 10, 2024 | HC Wainwright & Co. | Maintained | Buy | $10.00 |
| May 10, 2024 | Cantor Fitzgerald | Maintained | Overweight | $10.00 |
| May 10, 2024 | Raymond James | Maintained | Strong Buy | $10.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ADMA?

On Jul 15, 2026, Mizuho maintained ADMA Biologics at Outperform with a price target of $17.00.

## Similar Stocks

- [ALLO](https://www.lighthorse.io/tickers/allo) — Allogene Therapeutics, Inc. - Common Stock
- [ACAD](https://www.lighthorse.io/tickers/acad) — ACADIA Pharmaceuticals Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).